Suppr超能文献

成人急性呼吸衰竭体外膜肺氧合治疗项目组织立场文件。

Position paper for the organization of extracorporeal membrane oxygenation programs for acute respiratory failure in adult patients.

机构信息

1 Institute of Cardiometabolism and Nutrition, Groupe Hospitalier Pitié-Salpêtrière, Pierre Marie Curie University, Paris, France.

出版信息

Am J Respir Crit Care Med. 2014 Sep 1;190(5):488-96. doi: 10.1164/rccm.201404-0630CP.

Abstract

The use of extracorporeal membrane oxygenation (ECMO) for severe acute respiratory failure (ARF) in adults is growing rapidly given recent advances in technology, even though there is controversy regarding the evidence justifying its use. Because ECMO is a complex, high-risk, and costly modality, at present it should be conducted in centers with sufficient experience, volume, and expertise to ensure it is used safely. This position paper represents the consensus opinion of an international group of physicians and associated health-care workers who have expertise in therapeutic modalities used in the treatment of patients with severe ARF, with a focus on ECMO. The aim of this paper is to provide physicians, ECMO center directors and coordinators, hospital directors, health-care organizations, and regional, national, and international policy makers a description of the optimal approach to organizing ECMO programs for ARF in adult patients. Importantly, this will help ensure that ECMO is delivered safely and proficiently, such that future observational and randomized clinical trials assessing this technique may be performed by experienced centers under homogeneous and optimal conditions. Given the need for further evidence, we encourage restraint in the widespread use of ECMO until we have a better appreciation for both the potential clinical applications and the optimal techniques for performing ECMO.

摘要

鉴于体外膜肺氧合(ECMO)技术的不断进步,成人严重急性呼吸衰竭(ARF)的治疗中越来越多地使用 ECMO,但对于其使用的证据仍存在争议。由于 ECMO 是一种复杂、高风险和高成本的治疗方式,目前应在具有足够经验、容量和专业知识的中心进行,以确保其安全使用。本立场文件代表了在治疗严重 ARF 患者的治疗方法方面具有专业知识的一组国际医生和相关医疗保健工作者的共识意见,重点是 ECMO。本文的目的是为医生、ECMO 中心主任和协调员、医院院长、医疗保健组织以及区域、国家和国际政策制定者提供有关为成人 ARF 患者组织 ECMO 计划的最佳方法的描述。重要的是,这将有助于确保 ECMO 的安全和熟练应用,以便未来评估该技术的观察性和随机临床试验可以在经验丰富的中心在同质和最佳条件下进行。鉴于需要进一步的证据,我们鼓励在广泛使用 ECMO 之前保持谨慎,直到我们更好地了解其潜在的临床应用和进行 ECMO 的最佳技术。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验